| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 43.54B | 44.89B | 45.13B | 40.23B | 35.21B | 36.39B |
| Gross Profit | 5.08B | 5.32B | 5.91B | 6.14B | 5.65B | 5.86B |
| EBITDA | 2.28B | 2.79B | 2.93B | 3.55B | 3.38B | 2.42B |
| Net Income | 1.15B | 1.42B | 1.63B | 2.31B | 2.00B | 1.21B |
Balance Sheet | ||||||
| Total Assets | 51.82B | 52.34B | 51.38B | 47.27B | 42.85B | 38.91B |
| Cash, Cash Equivalents and Short-Term Investments | 20.43B | 20.68B | 20.00B | 21.42B | 21.03B | 19.93B |
| Total Debt | 7.22B | 7.28B | 7.27B | 6.77B | 6.34B | 5.22B |
| Total Liabilities | 12.98B | 13.48B | 14.25B | 12.36B | 11.22B | 9.22B |
| Stockholders Equity | 38.83B | 38.85B | 37.12B | 34.90B | 31.63B | 29.69B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.04B | -1.68B | 685.32M | 549.54M | 3.93B |
| Operating Cash Flow | 0.00 | 2.23B | -60.60M | 2.50B | 2.03B | 4.29B |
| Investing Cash Flow | 0.00 | -1.31B | 982.48M | -2.45B | -1.88B | -1.02B |
| Financing Cash Flow | 0.00 | -233.82M | 253.50M | 183.08M | 883.41M | 1.18B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥57.83B | 4.62 | ― | 2.44% | 3.34% | 26.28% | |
76 Outperform | ¥203.05B | 9.63 | 7.56% | 2.84% | 1.56% | -19.10% | |
71 Outperform | ¥66.03B | 13.32 | ― | 3.98% | 1.61% | -11.38% | |
65 Neutral | ¥34.28B | 14.63 | ― | 0.72% | -1.21% | 149.98% | |
63 Neutral | ¥59.85B | 22.47 | ― | 0.34% | 7.72% | 5.42% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
56 Neutral | ¥90.48B | 10.97 | ― | 3.59% | 6.25% | 246.08% |